Glass House Brands (GLAS) Construction in Progress (2021 - 2024)
Glass House Brands' (GLAS) quarterly Construction in Progress came in at $1.0 million in Q1 2024, down 89.91% on a QoQ basis from $10.2 million in Q4 2023.
Glass House Brands (GLAS) Construction in Progress (2021 - 2024) Analysis & Trends
Glass House Brands (GLAS) has 4 years of Construction in Progress data on file, last reported at $1.0 million in Q1 2024.
- On a quarterly basis, Construction in Progress changed N/A year-over-year to $1.0 million in Q1 2024; TTM through Mar 2024 was $1.0 million, a N/A change from a year earlier, with the FY2023 full-year figure at $10.2 million, changed N/A from the prior year.
- Construction in Progress for Q1 2024 stood at $1.0 million, down from $10.2 million in the prior quarter.
- Over the last five years, Construction in Progress for GLAS reached as high as $23.4 million in Q1 2022 and fell as low as $1.0 million in Q1 2024.
- Historically, Construction in Progress has averaged $11.6 million across 4 years, with a median of $11.0 million in 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | 10.17 Mn |
| Mar 31, 2022 | 23.37 Mn |
| Dec 31, 2021 | 11.87 Mn |